Galmed Pharmaceuticals Ltd. (GLMD)
NASDAQ: GLMD · Real-Time Price · USD
0.5953
+0.0103 (1.76%)
At close: May 13, 2026, 4:00 PM EDT
0.5899
-0.0054 (-0.91%)
After-hours: May 13, 2026, 7:27 PM EDT
Galmed Pharmaceuticals Market Cap
Galmed Pharmaceuticals has a market cap or net worth of $3.92 million as of May 13, 2026. Its market cap has increased by 39.93% in one year.
Market Cap
3.92M
Enterprise Value
-14.24M
1-Year Change
39.93%
Ranking
Category
Stock Price
$0.60
Market Cap Chart
Since March 13, 2014, Galmed Pharmaceuticals's market cap has decreased from $145.70M to $3.92M, a decrease of -97.31%. That is a compound annual growth rate of -25.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 12, 2026 | 3.90M | -4.88% |
| Dec 31, 2025 | 4.10M | -14.58% |
| Dec 31, 2024 | 4.80M | 166.67% |
| Dec 29, 2023 | 1.80M | -85.71% |
| Dec 30, 2022 | 12.60M | -72.43% |
| Dec 31, 2021 | 45.70M | -30.44% |
| Dec 31, 2020 | 65.70M | -45.93% |
| Dec 31, 2019 | 121.50M | 23.23% |
| Dec 31, 2018 | 98.60M | -11.33% |
| Dec 29, 2017 | 111.20M | 185.13% |
| Dec 30, 2016 | 39.00M | -53.85% |
| Dec 31, 2015 | 84.50M | 42.98% |
| Dec 31, 2014 | 59.10M | -59.44% |
| Mar 13, 2014 | 145.70M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GeoVax Labs | 4.83M |
| Pulmatrix | 4.74M |
| Indaptus Therapeutics | 4.22M |
| Matinas BioPharma Holdings | 4.09M |
| Alzamend Neuro | 4.07M |
| 60 Degrees Pharmaceuticals | 4.06M |
| VivoSim Labs | 4.02M |
| Azitra | 3.79M |